Skip to content

Novel Tricyclic Psychedelic Psychoplastogens as 5‑HT2C Agonists for Treating Neurological Diseases.

ACS Med Chem Lett June 29, 2025 DOI: 10.1021/acsmedchemlett.5c00381 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Peer reviewed

Abstract

Novel Tricyclic Psychedelic Psychoplastogens as 5‑HT2C Agonists for Treating Neurological Diseases.